Skip to Content

Perspective on the future standard of care for second-line treatment for patients with R/R LBCL

In this MEDtalk, Alexander Fosså, MD, PhD, Consultant, Department of Oncology, Oslo University Hospital, gives his perspective on CAR-T cell therapy for patients with relapsed/refractory large B-cell lymphoma.

Alexander Fosså

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top